rediff.com
e.g. Tata motors, Reliance MF, 500570
POLY MEDICURE LTD. - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015
Download announcement < Back
17 May 2024
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 17th May, 2024, at Crowne Plaza Today, Plot No.1, Community Centre, Okhla -I, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate &amp; Standalone) for the Fourth quarter and financial year ended on 31st March 2024. b. Recommendation of Dividend of Rs. 3 (Three Rupees) per Equity Shares (60%) of Rs. 5 each for the Financial Year 2023-24, subject to the approval of shareholders. c. Any Other Item. The Meeting was started at 10.30 am and concluded on 1:30 pm. Kindly take a note of the same for your further needful and oblige us.
View all announcements for POLY MEDICURE LTD. Source: BSE India